Page last updated: 2024-09-04

sodium salicylate and epidermal growth factor

sodium salicylate has been researched along with epidermal growth factor in 2 studies

Compound Research Comparison

Studies (sodium salicylate)	Trials (sodium salicylate)	Recent Studies (post-2010) (sodium salicylate)	Studies (epidermal growth factor)	Trials (epidermal growth factor)	Recent Studies (post-2010) (epidermal growth factor)
2,031	50	171	24,155	217	4,699

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Schwenger, P; Skolnik, EY; Vilcek, J	1
Alpert, D; Schwenger, P; Skolnik, EY; Vilcek, J	1

Other Studies

2 other study(ies) available for sodium salicylate and epidermal growth factor

Article	Year
Inhibition of tumor necrosis factor-induced p42/p44 mitogen-activated protein kinase activation by sodium salicylate. The Journal of biological chemistry, 1996, Apr-05, Volume: 271, Issue:14 Topics: Calcium-Calmodulin-Dependent Protein Kinases; Enzyme Activation; Epidermal Growth Factor; Humans; Kinetics; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Pertussis Toxin; Phosphotyrosine; Protein Kinase C; Protein-Tyrosine Kinases; Receptors, Tumor Necrosis Factor; Sodium Salicylate; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Virulence Factors, Bordetella	1996
Cell-type-specific activation of c-Jun N-terminal kinase by salicylates. Journal of cellular physiology, 1999, Volume: 179, Issue:1 Topics: Acetaminophen; Adenocarcinoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Calcium-Calmodulin-Dependent Protein Kinases; Chlorocebus aethiops; Colonic Neoplasms; COS Cells; Cyclooxygenase Inhibitors; Enzyme Activation; Epidermal Growth Factor; Fibroblasts; Humans; Hypertonic Solutions; Ibuprofen; Indomethacin; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; NF-kappa B; Organ Specificity; Osmotic Pressure; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-jun; Recombinant Fusion Proteins; Saline Solution, Hypertonic; Signal Transduction; Sodium Salicylate; Sorbitol; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	1999

Article

Year

Inhibition of tumor necrosis factor-induced p42/p44 mitogen-activated protein kinase activation by sodium salicylate.

The Journal of biological chemistry, 1996, Apr-05, Volume: 271, Issue:14

Topics: Calcium-Calmodulin-Dependent Protein Kinases; Enzyme Activation; Epidermal Growth Factor; Humans; Kinetics; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Pertussis Toxin; Phosphotyrosine; Protein Kinase C; Protein-Tyrosine Kinases; Receptors, Tumor Necrosis Factor; Sodium Salicylate; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Virulence Factors, Bordetella

1996

Cell-type-specific activation of c-Jun N-terminal kinase by salicylates.

Journal of cellular physiology, 1999, Volume: 179, Issue:1

Topics: Acetaminophen; Adenocarcinoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Calcium-Calmodulin-Dependent Protein Kinases; Chlorocebus aethiops; Colonic Neoplasms; COS Cells; Cyclooxygenase Inhibitors; Enzyme Activation; Epidermal Growth Factor; Fibroblasts; Humans; Hypertonic Solutions; Ibuprofen; Indomethacin; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; NF-kappa B; Organ Specificity; Osmotic Pressure; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-jun; Recombinant Fusion Proteins; Saline Solution, Hypertonic; Signal Transduction; Sodium Salicylate; Sorbitol; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1999